Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Merck's Discount Drug Program For Uninsured Will Not Include Income Limits

This article was originally published in The Pink Sheet Daily

Executive Summary

The program will allow uninsured patients, regardless of age or income level, to receive Merck drugs at discounts of 15%-40% at retail pharmacies. The program goes up against Together Rx Access, which is sponsored by a 10-member consortium of pharma companies.

You may also be interested in...



Postmarketing Trials, Not Discount Cards, Promote Drug Value, Harvard's Porter Says

Companies find themselves playing defense in debates on cost issues like reimportation because they have failed to demonstrate the value of their products, the Harvard Business School professor says. Merck's April announcement of a drug discount card program for the uninsured does not help promote value, Porter adds.

Postmarketing Trials, Not Discount Cards, Promote Drug Value, Harvard's Porter Says

Companies find themselves playing defense in debates on cost issues like reimportation because they have failed to demonstrate the value of their products, the Harvard Business School professor says. Merck's April announcement of a drug discount card program for the uninsured does not help promote value, Porter adds.

PhRMA Launches Rx Assistance Clearinghouse With National Ad Campaign

Print and television ads will encourage people to call the "Partnership for Prescription Assistance" toll-free number or visit the website for information. Application forms for the different public and private drug programs are available on the website.

Topics

UsernamePublicRestriction

Register

OM004078

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel